<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39372130</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-9361</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Therapeutic advances in infectious disease</Title><ISOAbbreviation>Ther Adv Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Catheter-associated urinary tract infections in critically Ill patients with COVID-19: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>20499361241278218</StartPage><MedlinePgn>20499361241278218</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20499361241278218</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/20499361241278218</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Catheter-associated urinary tract infections (CA-UTIs) pose a significant challenge in intensive care unit (ICU) patients with COVID-19.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The study aims to assess the prevalence of CA-UTIs, identify the causative pathogens and their resistance profiles, and determine the risk factors and outcomes associated with CA-UTIs in ICU patients with COVID-19.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Single-center, retrospective cohort study.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The study included 201 adult ICU patients diagnosed with COVID-19 between March 2020 and July 2021. Patients were categorized into CA-UTI (<i>n</i> = 56) and non-CA-UTI (<i>n</i> = 145) groups. Data on demographic characteristics, clinical course, treatment, and outcomes were collected. Logistic regression analysis was used to identify risk factors for CA-UTI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">CA-UTIs developed in 28% of patients (<i>n</i> = 56). Incidence density of 15.8 episodes per 1000 catheter days. The average onset occurrence is 7.2 days after ICU admission. Patients with CA-UTI had longer ICU stays (18.8 days vs 10.5 days, <i>p</i> &lt; 0.001) and more elevated mortality rates (75.0% vs 54.5%, <i>p</i> = 0.010), higher mechanical ventilation (MV) usage (98.2% vs 88.3%, <i>p</i> = 0.027), a longer average duration of MV (16.6 days vs 9.1 days, <i>p</i> &lt; 0.001). Longer ICU and hospital stays were significant risk factors for CA-UTI. Other factors, such as the use of corticosteroids, chronic organ insufficiency or immunocompromized status, female sex, age, diabetes mellitus, and the duration of urinary catheterization, did not show significant associations with CA-UTI risk in this cohort. Gram-negative bacteria, particularly <i>Klebsiella pneumoniae</i> (28 cases), was the most common pathogen, with a high prevalence of multidrug resistance (38.8%) with type ESBL, MBL, NDM, and OXA-48. The occurrence of multidrug resistant (MDR) organisms was 68.8%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings of this study underscore the prevalence of CA-UTIs in ICU patients with COVID-19, significantly impacting patient outcomes. Effective infection control and targeted antimicrobial therapy are crucial to managing these infections.</AbstractText><CopyrightInformation>© The Author(s), 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dąbrowska</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoszewicz</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6455-6962</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoszewicz</LastName><ForeName>Klaudia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Medical University of Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosel</LastName><ForeName>Juliusz</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stróż</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Immunology, Medical University of Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ładny</LastName><ForeName>Jerzy Robert</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Medical University of Bialystok, Bialystok, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czaban</LastName><ForeName>Sławomir Lech</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Medical University of Bialystok, Marii Skłodowskiej Curie 24A Bialystok 15-276, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Infect Dis</MedlineTA><NlmUniqueID>101606715</NlmUniqueID><ISSNLinking>2049-9361</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">catheter-associated urinary tract infections</Keyword><Keyword MajorTopicYN="N">multidrug-resistant organisms</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39372130</ArticleId><ArticleId IdType="pmc">PMC11452867</ArticleId><ArticleId IdType="doi">10.1177/20499361241278218</ArticleId><ArticleId IdType="pii">10.1177_20499361241278218</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ong CCH, Farhanah S, Linn KZ, et al.. Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance data. Antimicrob Resist Infect Control 2021; 10: 119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8358905</ArticleId><ArticleId IdType="pubmed">34384493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooton TM, Bradley SF, Cardenas DD, et al.. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625–663.</Citation><ArticleIdList><ArticleId IdType="pubmed">20175247</ArticleId></ArticleIdList></Reference><Reference><Citation>Blot S, Ruppé E, Harbarth S, et al.. Healthcare-associated infections in adult intensive care unit patients: changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 2022; 70: 103227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8892223</ArticleId><ArticleId IdType="pubmed">35249794</ArticleId></ArticleIdList></Reference><Reference><Citation>Cypress BS. COVID-19: the economic impact of a pandemic on the healthcare delivery system in the United States. Nurs Forum 2022; 57: 323–327.</Citation><ArticleIdList><ArticleId IdType="pubmed">34845736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoszewicz M, Czaban SL, Bartoszewicz K, et al.. Bacterial bloodstream infection in critically ill patients with COVID-19: a retrospective cohort study. Ther Adv Infect Dis 2023; 10: 20499361231207178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10590042</ArticleId><ArticleId IdType="pubmed">37869469</ArticleId></ArticleIdList></Reference><Reference><Citation>Werneburg GT. Catheter-associated urinary tract infections: current challenges and future prospects. Res Rep Urol 2022; 14: 109–133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992741</ArticleId><ArticleId IdType="pubmed">35402319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartoszewicz K, Bartoszewicz M, Gradkowski W, et al.. Analysis of prognostic factors in critically ill patients with COVID-19. PLoS ONE 2024; 19: e0302248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11210843</ArticleId><ArticleId IdType="pubmed">38935767</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al.. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4: e296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2020495</ArticleId><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, Polk BF, Murdock B, et al.. Risk factors for nosocomial urinary tract infection. Am J Epidemiol 1986; 124: 977–985.</Citation><ArticleIdList><ArticleId IdType="pubmed">3776980</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataraman R, Manuel GG, JR N, et al.. Prevalence, risk factors, causative organism and antibiotic susceptibility of catheter associated urinary tract infections. Int J Res Med Sci 2023; 12: 183–187.</Citation></Reference><Reference><Citation>Patel PK, Advani SD, Kofman AD, et al.. Strategies to prevent catheter-associated urinary tract infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023; 44: 1209–1231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11287483</ArticleId><ArticleId IdType="pubmed">37620117</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC. R: A Language and environment for statistical computing (Version 4.1) [Computer software], 2021.</Citation></Reference><Reference><Citation>The jamovi p. jamovi (Version 2.3) [Computer software], 2022.</Citation></Reference><Reference><Citation>Bartoszewicz M, Kosel J, Nadolny K, et al.. Ventilator-associated pneumonia among patients with COVID-19: a retrospective cohort study. Emerg Med Serv 2023; 10: 210–216.</Citation></Reference><Reference><Citation>Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268–281.</Citation><ArticleIdList><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem M, Syed Khaja AS, Hossain A, et al.. Catheter-associated urinary tract infection in intensive care unit patients at a Tertiary Care Hospital, Hail, Kingdom of Saudi Arabia. Diagnostics (Basel) 2022; 12: 20220712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9322978</ArticleId><ArticleId IdType="pubmed">35885599</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardi T, Pintado V, Gomez-Rojo M, et al.. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis 2021; 40: 495–502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778834</ArticleId><ArticleId IdType="pubmed">33389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Despotovic A, Milosevic B, Cirkovic A, et al.. The impact of COVID-19 on the profile of hospital-acquired infections in adult intensive care units. Antibiotics (Basel) 2021; 10: 20210923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8532680</ArticleId><ArticleId IdType="pubmed">34680727</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Laethem J, Wuyts SCM, Pierreux J, et al.. Presumed urinary tract infection in patients admitted with COVID-19: are we treating too much? Antibiotics (Basel) 2021; 10: 20211206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8698875</ArticleId><ArticleId IdType="pubmed">34943705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zand F, Vakili H, Asmarian N, et al.. Unintended impact of COVID-19 pandemic on the rate of catheter related nosocomial infections and incidence of multiple drug resistance pathogens in three intensive care units not allocated to COVID-19 patients in a large teaching hospital. BMC Infect Dis 2023; 23: 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9821351</ArticleId><ArticleId IdType="pubmed">36609225</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Decker SG, Bosch N, Murphy J. Catheter-associated urinary tract infection reduction in critical care units: a bundled care model. BMJ Open Qual 2021; 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8705224</ArticleId><ArticleId IdType="pubmed">34949580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubde D, Badge AK, Ugemuge S, et al.. Importance of hospital infection control. Cureus 2023; 15: e50931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10801286</ArticleId><ArticleId IdType="pubmed">38259418</ArticleId></ArticleIdList></Reference><Reference><Citation>Stróż S, Kosiorek P, Stasiak-Barmuta A. The COVID-19 inflammation and high mortality mechanism trigger. Immunogenetics 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38063879</ArticleId></ArticleIdList></Reference><Reference><Citation>Radu VD, Costache RC, Onofrei P, et al.. Multidrug-resistant (MDR) urinary tract infections associated with gut microbiota in CoV and Non-CoV patients in a urological clinic during the pandemic: a single center experience. Antibiotics (Basel) 2023; 12: 20230528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10295671</ArticleId><ArticleId IdType="pubmed">37370292</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>